Navigation Links
New Science Fiction Novel Paints Terrifying Picture of Dystopian Future: Young Author Receives Glowing Reviews
Date:2/23/2013

Korora, NSW (PRWEB) February 24, 2013

In a time when the imaginings of science fiction writers are frequently being brought to life by the realities of technology, it is not hard to think of a world in which our wildest technological fantasies are made commonplace. Neural microchips, mechanical limbs, organic metals, DNA splicing - how far away can these scientific achievements really be? One independent author has taken these ideas one step further, turning them into a believable, fast-paced and thrilling science-fiction series, so that others might be able to share his dystopian vision of the future of our world.

Jeremy Bowden has recently achieved the first step in this goal with the release of the first novel in his epic new series, entitled Bioweapon: New Beginnings. The book was released in November through U.S. Based self-publishing company - Xlibris, and is due for re-release through an Australian self-publishing company later this year. The novel has received glowing reviews from every angle, (see Fantascize for in-depth review) and there is already another episode in the series due for release later in 2013.

The story itself brings together a number of current social and political developments, highlighting contemporary technological breakthroughs to portray "an all too plausible future which utilizes pressing issues such as climate change, global disarmament, a desensitizing media, and consumerism, treating each as the real problems they are, but then twisting their resolution into something even more threatening." (Fantascize.com)

The ‘Bioweapon’ series is not only an action-packed and imaginative sci-fi thriller, but it is also a social commentary raising very serious questions and concerns about our current society and the direction in which it is moving. An exploration of the concept of freedom runs beneath the entire novel often reflecting its own strained survival in contemporary society.

"'Bioweapon' is perhaps the most enjoyable and intelligently written novel I’ve read this year. Personally, I cannot recommend it highly enough. Well done, and I eagerly look forward to Part II." - Review by J. P. Bowman of Fantascize.com.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10454578.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research with Seed Round Investment in Sanguine BioSciences
2. A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.
3. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
4. Dr. Wayne Hachey Joins Protein Sciences Leadership Team
5. Art Levinson, Sergey Brin and Anne Wojcicki, Mark Zuckerberg and Priscilla Chan, and Yuri Milner Announce the Breakthrough Prize in Life Sciences
6. Food science expert: Genetically modified crops are overregulated
7. Bayer CropScience Innovation Plus Platform Offers Customizable Tools
8. Research article coauthored by Pitt professor named best article of the year by Science
9. Chicago to Welcome Data Science, Big Data and Data Mining Leaders at the 19th International ACM Knowledge Discovery and Data Mining Conference, KDD 2013
10. Up to the Challenge: Careers in Science in the Midst of Drastic Change, According to Wysebridge Patent Bar Review
11. Charm Sciences EZ System Accepted for Antibiotic Testing of Raw Milk in the US NCIMS Residue Screening Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... , Feb. 17, 2017  If only one ... had a mutation-conferring resistance to chemotherapy, thousands of ... research has focused on finding these mutations in ... from circulating tumor DNA in blood — to ... therapeutics. Unfortunately, however, detecting these genetic ...
(Date:2/16/2017)... 16, 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology ... a better treatment for triple negative breast cancer (TNBC), announced ... France program. The YEi Start in ... to help entrepreneurs grow their business in France ... American companies selected to complete an intensive one week immersion ...
(Date:2/16/2017)... , Feb. 16, 2017   Capricor ... a clinical-stage biotechnology company developing first-in-class biological therapies ... that it has elected to terminate its license ... peptide receptor agonists, including Cenderitide. "Our ... move as we prioritize our efforts to advance ...
(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
Breaking Biology Technology:
(Date:2/9/2017)... 2017 The biomass boiler market report by ... boiler market globally in terms of revenue (US$ Mn) ... market for biomass boilers has been segmented on the ... country/region. The market based on feedstock type, has been ... & energy crops, urban residues, and others. On the ...
(Date:2/8/2017)... Feb. 7, 2017 The biometrics market ... the confluence of organizations, desires to better authenticate ... systems (password and challenge questions), biometrics is quickly ... systems. The market is driven by use cases, ... consumer and enterprise uses cases, with consumer-facing use ...
(Date:2/7/2017)... 2017 Ipsidy Inc. ( www.ipsidy.com ... IDGS], ("Ipsidy" or the "Company") a provider of secure, ... is pleased to announce the following changes as part ... January 31, 2017, Philip D. Beck was ... President.  An experienced payment industry professional and public company ...
Breaking Biology News(10 mins):